Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow Reinvestment Rate
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow Reinvestment Rate of 2.64x as of September 2023, reinvesting €148.38 Million (capex €80.69 Million plus investments €-67.69 Million) from operating cash flow of €56.11 Million. See how much free cash does Shandong Xinhua Pharmaceutical Company L generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. For the full cash flow conversion analysis, see XIN cash flow conversion.
Annual Cash Flow Reinvestment Rate for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year capital reinvestment analysis for Shandong Xinhua Pharmaceutical Company Limited. See Shandong Xinhua Pharmaceutical Company L financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | €125.40 Million | €533.73 Million | €115.60 Million | ▼ -60.8% |
| 2024 | 0.60x | €220.60 Million | €367.61 Million | €212.42 Million | ▼ -74.7% |
| 2023 | 2.38x | €630.24 Million | €265.28 Million | €325.13 Million | ▲ +280.3% |
| 2022 | 0.62x | €473.66 Million | €758.24 Million | €244.76 Million | ▼ -66.8% |
| 2021 | 1.88x | €486.92 Million | €259.12 Million | €249.23 Million | ▲ +154.6% |
| 2020 | 0.74x | €310.19 Million | €420.19 Million | €280.19 Million | ▼ -39.3% |
| 2019 | 1.22x | €423.28 Million | €348.27 Million | €366.51 Million | ▼ -11.6% |
| 2018 | 1.37x | €445.21 Million | €323.91 Million | €388.44 Million | ▲ +82.1% |
| 2017 | 0.75x | €294.31 Million | €389.97 Million | €261.11 Million | ▼ -29.5% |
| 2016 | 1.07x | €470.36 Million | €439.35 Million | €227.07 Million | ▲ +97.0% |
| 2015 | 0.54x | €189.42 Million | €348.64 Million | €169.09 Million | ▼ -32.4% |
| 2014 | 0.80x | €278.23 Million | €346.34 Million | €260.17 Million | ▼ -76.7% |
| 2013 | 3.45x | €362.58 Million | €104.99 Million | €344.53 Million | — |